Sign in

You're signed outSign in or to get full access.

Michael Stewart

Lead Independent Director at MEDICAL PROPERTIES TRUST
Board

About Michael G. Stewart

Lead Independent Director of Medical Properties Trust (MPW) since 2016; age 69. Stewart has a legal and healthcare governance background, previously serving as MPW’s Executive Vice President, General Counsel and Secretary (2005–2010), and is currently a private investor and published author. He holds a B.S. in Business Administration (Information Systems) from Auburn University and a J.D. from Cumberland School of Law at Samford University . The Board affirms his independence under NYSE standards, and he presides over executive sessions as Lead Independent Director .

Past Roles

OrganizationRoleTenureCommittees/Impact
Medical Properties Trust, Inc.EVP, General Counsel & Secretary2005–2010Senior legal executive; corporate governance and healthcare issues
Berkowitz, Lefkovits, Isom & Kushner (now Baker Donelson)AttorneyNot disclosedPractice: corporate, healthcare, litigation, employment, labor
Constangy, Brooks & SmithAttorneyNot disclosedPractice: corporate, healthcare, litigation, employment, labor
Complete Health Services, Inc. (later United Healthcare of the South)Vice President & General CounselNot disclosedHealthcare legal leadership

External Roles

OrganizationRoleTenureCommittees/Impact
Private InvestorPrivate investorCurrentNot disclosed
G.P. Putnam’s Sons / Random HouseAuthor of four novelsNot disclosedPublished author
Public company boardsNone disclosed in MPW proxy

Board Governance

  • Independence: Board determined Stewart is independent under NYSE standards .
  • Lead Independent Director: Presides at executive sessions; liaison to Chair; oversees annual board self-evaluation; contact available ([email protected]) .
  • Committee memberships:
    • Compensation Committee (member; Chair: C. Reynolds Thompson, III) .
    • Environmental and Social Responsibility Committee (member; Chair: Caterina A. Mozingo) .
    • Ethics, Nominating and Corporate Governance Committee (member; Chair: Elizabeth N. Pitman) .
  • Meetings and attendance: In 2024, Board met 7 times; Compensation 5; Ethics/Nominating 4; Environmental & Social 1; each incumbent director attended at least 75% of Board and committee meetings; risk matters covered in Board meetings (Risk Committee did not meet) .
2024 Board/CommitteeMeetings HeldStewart Member (Y/N)
Board of Directors7 Y
Compensation5 Y
Ethics, Nominating & Corporate Governance4 Y
Environmental & Social Responsibility1 Y
Risk0 (covered in Board) N
Audit4 N
Investment2 (written consent) N

Fixed Compensation (Director)

ComponentAmountNotes
Annual director cash retainer (2024)$115,000 Applies to all non-employee directors
Lead Independent Director retainer (2024)$50,000 Additional cash retainer for Lead Independent Director
Fees earned in cash (Stewart, 2024)$165,000 Sum of base + Lead Independent retainer; Stewart not a committee chair
Director Retirement PolicyFinal annual retainer ÷ 12 × years of service (lump sum at retirement) Adopted Feb 2017

Performance Compensation (Director)

Equity AwardGrant DateSharesGrant-Date Fair ValueVesting
Restricted stock (annual grant)Mar 15, 202429,914 $128,032 (at $4.28/share) 3-year, equal quarterly vesting
Restricted stock (annual grant)20239,675 Not separately disclosed for Stewart3-year, equal quarterly vesting
Restricted stock (annual grant)20225,552 Not separately disclosed for Stewart3-year, equal quarterly vesting
  • Options: Company states it has not issued options, warrants or rights under its 2019 Plan; director equity is restricted stock/RSUs only .
  • Performance metrics: No director-specific performance metrics disclosed; director equity awards are time-based .

Other Directorships & Interlocks

CategoryDetail
Public company directorshipsNone disclosed for Stewart in MPW proxy
InterlocksStewart served as MPW EVP/GC (2005–2010); served on Compensation Committee in 2024; committee members deemed independent; no relationships requiring disclosure under SEC rules in 2024

Expertise & Qualifications

  • Skills per MPW’s matrix include Strategic Planning, Executive Leadership, Risk Management, REIT/Real Estate, Health Care Industry, Legal/Regulatory .
  • Legal and healthcare governance experience; prior GC roles; private consulting to physician groups .
  • Education: Auburn University (B.S., Information Systems); Cumberland School of Law (J.D.) .

Equity Ownership

MeasureValue
Beneficial ownership (Mar 18, 2025)221,245 shares; less than 1% outstanding
Unvested director stock (Dec 31, 2024)26,920 shares
Ownership guidelines (directors)3× annual fee; Company discloses directors are in compliance
Hedging/pledgingProhibited by Company policy

Insider Trades (Form 4)

Transaction DateTypeSharesPricePost-Transaction OwnershipSEC Filing
Feb 6, 2023Award (A)9,675$0224,111 [ReadFile: line 82–90]https://www.sec.gov/Archives/edgar/data/1287865/000128786523000014/0001287865-23-000014-index.htm
Mar 15, 2024Award (A)29,914$0254,025 [ReadFile: line 63–73]https://www.sec.gov/Archives/edgar/data/1287865/000095017024032373/0000950170-24-032373-index.htm
Oct 9, 2024Sale (S)32,780$5.46221,245 [ReadFile: line 41–56]https://www.sec.gov/Archives/edgar/data/1287865/000095017024113821/0000950170-24-113821-index.htm
Apr 10, 2025Award (A)23,855$0245,100 [ReadFile: line 23–37]https://www.sec.gov/Archives/edgar/data/1287865/000095017025053824/0000950170-25-053824-index.htm
May 5, 2025Sale (S)29,000$5.20216,100 [ReadFile: line 5–19]https://www.sec.gov/Archives/edgar/data/1287865/000095017025063782/0000950170-25-063782-index.htm

Governance Assessment

  • Strengths:

    • Independent status affirmed; serves as Lead Independent Director with clearly defined responsibilities and regular executive sessions, improving board independence and oversight .
    • Active committee engagement (Compensation; Ethics/Nominating/CG; Environmental & Social), with independent compensation consultant and committee independence assessments; positive signal on governance process .
    • Ownership alignment mechanisms: director stock grants with multi-year vesting, anti-hedging/anti-pledging policy, and director ownership guidelines with disclosed compliance .
    • Attendance: all incumbent directors met the 75% attendance threshold; all directors attended the 2024 annual meeting .
  • Potential conflicts / red flags:

    • Former MPW executive (EVP/GC, 2005–2010) currently on Compensation Committee—Board deems committee independence and no SEC-related relationships in 2024, but prior executive affiliation is a governance sensitivity; monitor continued independence and objectivity .
    • Related party: one family member of Stewart employed by MPW in 2024 (non-executive; $120k–$345k total compensation) reviewed under related person policy—acceptable process disclosed but represents related-party exposure to track .
    • Insider sales in Oct 2024 and May 2025; while not inherently problematic, sales during turnaround periods can be perceived negatively by some investors; context provided via ongoing equity awards and policy constraints [ReadFile: line 41–56] [ReadFile: line 5–19].
  • Shareholder sentiment:

    • Company disclosed lower Say-on-Pay support over the past two years and adjusted executive compensation design (stock-price-based performance awards) following outreach; continued monitoring of vote results advised .

Director Compensation Mix

YearCash Fees (Stewart)Stock Award Fair ValueTotal
2024$165,000 $128,032 $293,032
2023$— (individual line shows $115k for base fee; Lead Independent retainer applies in 2024 disclosure; see table)$128,032 (for non-employee directors) $— (total for Stewart not provided in 2023 table; 2024 table is provided)

Note: The 2024 director stock award fair value was based on $4.28 per share; awards vest over three years in equal quarterly installments . MPW has not granted options/warrants/rights under its 2019 Plan; director equity is restricted stock/RSUs .

Related Party Transactions (Policy & Disclosures)

  • Policy: All related person transactions require advance approval by a majority of disinterested directors or prompt ratification upon recognition; alignment with Item 404 of Regulation S-K .
  • 2024 employee relatives: Stewart had one family member employed by MPW (non-executive; compensation $120k–$345k; comparable to peers; benefits on same basis as other employees) .

Committee Structure and Consultant Independence

  • Compensation Committee members (2024): Chair C. Reynolds Thompson, III; members Michael G. Stewart; D. Paul Sparks, Jr.; Board assessed independence of members and of consultant Gressle & McGinley (no conflicts) .
  • Non-employee director compensation reviewed with Gressle & McGinley in 2024 .

Additional Governance Policies

  • Anti-hedging and anti-pledging for directors and employees .
  • Corporate governance guidelines, code of ethics, proxy access, majority voting, mandatory director retirement age; Board composition and skills matrix disclosed .

Summary Signals for Investors

  • Stewart’s Lead Independent Director role and committee participation support board effectiveness and independent oversight .
  • Related-party family employment and insider sales merit ongoing monitoring; Board policies and disclosures mitigate but do not eliminate perceived risk [ReadFile: line 41–56] [ReadFile: line 5–19].
  • Director pay structure emphasizes time-based equity and standard cash retainer; no director performance equity metrics disclosed; ownership guidelines and anti-pledging policies enhance alignment .